Bio-Techne TECH
NASDAQ TECH
$72.42 -0.03 (-0.05%)
As of: Sep 4, 2026 · 1:35 PM EDT

Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014)

Bio-Techne (TECH) posted quarterly Amortization - Intangibles of $5.7 million for Q3 2014, up 161.79% year-over-year from $2.2 million in Q3 2013, and up 161.79% quarter-over-quarter from $2.2 million in Q3 2013.

Analysis

Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014) Analysis & Trends

Bio-Techne's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $5.7 million for Q3 2014.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 5.73 Mn
Sep 30, 2013 2.19 Mn
Mar 31, 2011 170,000.00
Dec 31, 2010 171,000.00
Sep 30, 2010 170,000.00
Mar 31, 2010 240,000.00
Dec 31, 2009 240,000.00
Sep 30, 2009 240,000.00